Literature DB >> 27815759

Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma.

Shenghua Hao1, Ping Fan2, Shaofei Chen2, Caixue Tu2, Chidan Wan2.   

Abstract

BACKGROUND AND OBJECTIVES: Intrahepatic recurrence after hepatectomy for hepatocellular carcinoma (HCC) includes intrahepatic metastasis (IM) and multicenter occurrence (MO). The risk factors for these two types of intrahepatic recurrence have not been well defined.
METHODS: The type of intrahepatic recurrence was determined based on histopathological features of 93 HCC patients who underwent a repeat hepatectomy for recurrent HCC. Various clinical and pathological factors were analyzed to define distinct risk factors for different types of intrahepatic recurrence.
RESULTS: The recurrence rates at 1, 2, 3, 5, and 8 years postoperatively were 22.4, 42.9, 61.2, 85.7, and 100 %, respectively, in patients with IM and 5.0, 25.0, 45.5, 67.5, and 100 %, respectively, in patients with MO (p = 0.005). A total of 16 clinical and pathological factors were tested in univariable and multivariable analyses. We found that large-size tumor (>5 cm), multiple tumors (two or more), and vascular invasion were significantly associated with IM recurrence, and liver cirrhosis and Ishak hepatic inflammatory activity were highly associated with MO recurrence. In addition, blood transfusion and a high hepatitis B virus (HBV)-DNA load (>2000 IU/ml) were independent risk factors common to both IM and MO recurrences.
CONCLUSIONS: IM and MO recurrences were associated with distinct risk factors, while blood transfusion and high HBV-DNA load (>2000 IU/ml) were independent risk factors common to both IM and MO recurrences.

Entities:  

Keywords:  Hepatocellular carcinoma; Intrahepatic metastasis; Multicenter occurrence; Recurrence; Risk factor

Mesh:

Year:  2016        PMID: 27815759     DOI: 10.1007/s11605-016-3311-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  31 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 3.  Transfusion-related immunomodulation (TRIM): an update.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Blood Rev       Date:  2007-09-04       Impact factor: 8.250

4.  Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning.

Authors:  R Saeki; H Nagai; S Kaneko; M Unoura; N Yamanaka; E Okamoto; K Kobayashi; K Matsubara
Journal:  J Hepatol       Date:  2000-07       Impact factor: 25.083

5.  Clonal origin of recurrent hepatocellular carcinomas.

Authors:  P J Chen; D S Chen; M Y Lai; M H Chang; G T Huang; P M Yang; J C Sheu; S C Lee; H C Hsu; J L Sung
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

6.  The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.

Authors:  Y Makino; A Yamanoi; T Kimoto; O N El-Assal; H Kohno; N Nagasue
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

7.  Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  J Yamamoto; T Kosuge; T Takayama; K Shimada; S Yamasaki; H Ozaki; N Yamaguchi; S Mizuno; M Makuuchi
Journal:  Surgery       Date:  1994-03       Impact factor: 3.982

8.  Intratumoral DNA heterogeneity of small hepatocellular carcinoma.

Authors:  S Okada; H Ishii; H Nose; T Okusaka; A Kyogoku; M Yoshimori; M Sakamoto; S Hirohashi
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

9.  Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV.

Authors:  Jian Wang; Qiang Li; Yan Sun; Hong Zheng; Yunlong Cui; Haixin Li; Hongyuan Zhou; Xishan Hao
Journal:  Surg Oncol       Date:  2008-07-18       Impact factor: 3.279

Review 10.  Platelet microparticles and cancer: An intimate cross-talk.

Authors:  Hadi Goubran; Waleed Sabry; Rami Kotb; Jerard Seghatchian; Thierry Burnouf
Journal:  Transfus Apher Sci       Date:  2015-10-27       Impact factor: 1.764

View more
  16 in total

1.  Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma: What Is More Is About Different Therapeutic Strategies.

Authors:  Xiaoyun Zhang; Chuan Li; Tianfu Wen
Journal:  J Gastrointest Surg       Date:  2017-08-31       Impact factor: 3.452

2.  Overexpression of long non-coding RNAs DUXAP9 and DUXAP10 is associated with prognosis in patients with hepatocellular carcinoma after hepatectomy.

Authors:  Qian Zhu; Jian Liu; Jie Tang; De-Liang Guo; Yun Li; Rui Duan
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern.

Authors:  Xiaoyun Zhang; Chuan Li; Tianfu Wen; Wei Peng; Lunan Yan; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2017-12-14       Impact factor: 3.199

Review 4.  Intrahepatic recurrence of hepatocellular carcinoma after resection: an update.

Authors:  Maria Tampaki; George Vasileios Papatheodoridis; Evangelos Cholongitas
Journal:  Clin J Gastroenterol       Date:  2021-03-27

5.  A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma.

Authors:  Wenyu Gao; Wentao Wang; Danjun Song; Chun Yang; Kai Zhu; Mengsu Zeng; Sheng-Xiang Rao; Manning Wang
Journal:  Radiol Med       Date:  2022-02-07       Impact factor: 3.469

6.  A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation.

Authors:  Liting Wen; Shuping Weng; Chuan Yan; Rongping Ye; Yuemin Zhu; Lili Zhou; Lanmei Gao; Yueming Li
Journal:  Front Oncol       Date:  2021-04-29       Impact factor: 6.244

7.  Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection.

Authors:  Narongsak Rungsakulkij; Wikran Suragul; Somkit Mingphruedhi; Pongsatorn Tangtawee; Paramin Muangkaew; Suraida Aeesoa
Journal:  World J Clin Cases       Date:  2018-06-16       Impact factor: 1.337

Review 8.  Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update.

Authors:  Jia-Zhou Ye; Yan-Yan Wang; Tao Bai; Jie Chen; Bang-De Xiang; Fei-Xiang Wu; Le-Qun Li
Journal:  Oncotarget       Date:  2017-06-27

9.  Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy.

Authors:  Yuan Dong; Weiwei Yan; Shi-Long Zhang; Mu-Zi-He Zhang; Yan-Ping Zhou; Hai-Hui Ling; Meng Ning; Yanling Zhao; Ang Huang; Ping Zhang
Journal:  Oncotarget       Date:  2017-12-11

10.  Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.

Authors:  Narongsak Rungsakulkij; Wikran Suragul; Somkit Mingphruedhi; Pongsatorn Tangtawee; Paramin Muangkaew; Suraida Aeesoa
Journal:  Infect Agent Cancer       Date:  2018-06-08       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.